ASSUT EUROPE SPA
IT-MF-000018178 · Italy · Rome
ASSUT EUROPE SPA is registered in the European database on medical devices as a manufacturer, with 5 673 devices declared. It has a similarly named entry in the FDA register that we have not verified.
What this manufacturer declares
| Class I | 5 673 |
|---|
Among these devices, 5 673 are declared sterile, 5 673 implantable.
Devices declared under this manufacturer
- ASSUFIL
- ASSUFIL FAST
- ASSUFIL MONOFILAMENTO
- ASSUMESH
- ASSUNYL
- ASSUPRO
- Definisse
- FILBLOC
- FILBLOC 90
- FILBLOC PERMANENT
- GLICOFIL·LAC
- GLICOFIL·LAC fast
Showing 12 of 5 673 declared devices.
Catalogue references include 10FSPAH, AM0208BR, FR249HHFAQ, FS407HHAB, FS423HHFST, FS979HHAH.
European nomenclature codes declared: H010101020101, H010101010104, H010101020201,H010101020202,H010101020203, H010101010301, H010101010303, H010101010101.
United States market access
| FDA establishment register | Similar name found — unverified |
|---|---|
| Matched entry | Assut Europe S.P.A. (IT) · FDA 9617547 |
| Devices in EUDAMED | 5 673 |
| Country of registration | Italy |
⚠️ A similar name exists; we do not assert it is the same company — why.
Device-level evidence
| Devices with a numeric GTIN | 5 673 |
|---|---|
| Found in the U.S. device database | 0 |
| Share | 0.0 % |
Canadian market access
| Health Canada licence listing | Not found in the Canadian register |
|---|
⚠️ Canada lists no Class I devices at all — what that excludes.
Notified body certificates
| Certificate | Status | Expiry |
|---|---|---|
CVD0060260126 | issued | 2028-08-07 |
CVD0051260326 | supplemented | 2028-08-07 |
CVD0050250126 | supplemented | 2028-08-07 |
CVD0049250126 | supplemented | 2028-08-07 |
CVD0048250326 | supplemented | 2028-08-07 |
CVD004725 | issued | 2028-08-07 |
CVD0044250226 | supplemented | 2028-08-07 |
CVD0041240324 | supplemented | 2028-08-07 |